Priego EM - Search Results

1

Genome bioinformatic analysis of nonsynonymous SNPs.

Burke DF, Worth CL, Priego EM, Cheng T, Smink LJ, Todd JA, Blundell TL. Burke DF, et al. Among authors: priego em. BMC Bioinformatics. 2007 Aug 20;8:301. doi: 10.1186/1471-2105-8-301. BMC Bioinformatics. 2007. PMID: 17708757 Free PMC article.

2

The crystal structure of the BAR domain from human Bin1/amphiphysin II and its implications for molecular recognition.

Casal E, Federici L, Zhang W, Fernandez-Recio J, Priego EM, Miguel RN, DuHadaway JB, Prendergast GC, Luisi BF, Laue ED. Casal E, et al. Among authors: priego em. Biochemistry. 2006 Oct 31;45(43):12917-28. doi: 10.1021/bi060717k. Biochemistry. 2006. PMID: 17059209 Free PMC article.

3

Role of histidine-85 in the catalytic mechanism of thymidine phosphorylase as assessed by targeted molecular dynamics simulations and quantum mechanical calculations.

Mendieta J, Martín-Santamaría S, Priego EM, Balzarini J, Camarasa MJ, Pérez-Pérez MJ, Gago F. Mendieta J, et al. Among authors: priego em. Biochemistry. 2004 Jan 20;43(2):405-14. doi: 10.1021/bi034793o. Biochemistry. 2004. PMID: 14717594

4

Towards new thymidine phosphorylase/PD-ECGF inhibitors based on the transition state of the enzyme reaction.

Priego EM, Mendieta J, Gago F, Balzarini J, De Clercq E, Camarasa MJ, Pérez-Pérez MJ. Priego EM, et al. Nucleosides Nucleotides Nucleic Acids. 2003 May-Aug;22(5-8):951-3. doi: 10.1081/NCN-120022693. Nucleosides Nucleotides Nucleic Acids. 2003. PMID: 14565319

5

Thymidine phosphorylase inhibitors: recent developments and potential therapeutic applications.

Pérez-Pérez MJ, Priego EM, Hernández AI, Camarasa MJ, Balzarini J, Liekens S. Pérez-Pérez MJ, et al. Among authors: priego em. Mini Rev Med Chem. 2005 Dec;5(12):1113-23. doi: 10.2174/138955705774933301. Mini Rev Med Chem. 2005. PMID: 16375757 Review.

6

5'-O-tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase.

Casanova E, Hernandez AI, Priego EM, Liekens S, Camarasa MJ, Balzarini J, Pérez-Pérez MJ. Casanova E, et al. Among authors: priego em. J Med Chem. 2006 Sep 7;49(18):5562-70. doi: 10.1021/jm0605379. J Med Chem. 2006. PMID: 16942029

7

Pyrido[2,1-f]purine-2,4-dione derivatives as a novel class of highly potent human A(3) adenosine receptor antagonists.

Priego EM, von Frijtag Drabbe Kuenzel J, IJzerman AP, Camarasa MJ, Pérez-Pérez MJ. Priego EM, et al. J Med Chem. 2002 Aug 1;45(16):3337-44. doi: 10.1021/jm0208469. J Med Chem. 2002. PMID: 12139445

8

Synthesis and evaluation of thymine-derived carboxamides against mitochondrial thymidine kinase (TK-2) and related enzymes.

Priego EM, Balzarini J, Karlsson A, Camarasa MJ, Pérez-Pérez MJ. Priego EM, et al. Bioorg Med Chem. 2004 Oct 1;12(19):5079-90. doi: 10.1016/j.bmc.2004.07.036. Bioorg Med Chem. 2004. PMID: 15351391

9

Mitochondrial thymidine kinase inhibitors.

Pérez-Pérez MJ, Hernández AI, Priego EM, Rodríguez-Barrios F, Gago F, Camarasa MJ, Balzarini J. Pérez-Pérez MJ, et al. Among authors: priego em. Curr Top Med Chem. 2005;5(13):1205-19. doi: 10.2174/156802605774463097. Curr Top Med Chem. 2005. PMID: 16305527 Review.

10

Selective human adenosine A3 antagonists based on pyrido[2,1-f]purine-2,4-diones: novel features of hA3 antagonist binding.

Priego EM, Pérez-Pérez MJ, von Frijtag Drabbe Kuenzel JK, de Vries H, Ijzerman AP, Camarasa MJ, Martín-Santamaría S. Priego EM, et al. ChemMedChem. 2008 Jan;3(1):111-9. doi: 10.1002/cmdc.200700173. ChemMedChem. 2008. PMID: 18000937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters